PharmaForm will develop the drug products to deliver Pear Tree’s confidential drug substances to the vaginal cavity.
Stephen Rocamboli, president of Pear Tree Pharmaceuticals, said: “We are pleased to be working with PharmaForm on these important products. We believe PharmaForm’s recognized expertise in drug product development and delivery to the vaginal cavity will help us accelerate our program strategies.”